Clinical Trial Update: To Evaluate the Efficacy and Safety of LIZTOX in Subjects with Benign Masseteric Hypertrophy [Phase 3]

View source ↗

Summary

This clinical trial update shows that Huons Biopharma is evaluating LIZTOX for benign masseteric hypertrophy in a Phase 3 trial, which is currently active but n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Masseteric Hypertrophy

Drugs mentioned

• LIZTOX

Snippet

Sponsor: Huons Biopharma | Conditions: Benign Masseteric Hypertrophy | Phase 3 | Status: ACTIVE_NOT_RECRUITING